NEW YORK, Nov. 5 — A unit of Swedish genomic firm Pyrosequencing and The Cleveland Clinic Foundation announced plans on Monday to co-develop rapid identification and diagnostic tests for mycobacteria. 

This partnership, which was launched to create faster and higher-quality tests for diagnosing and identifying Mycobacterium tuberculosis  and Mycobacterium avium,  is part of Pyrosequencing’s broad plan to enter the molecular diagnostic-testing arena. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.